vs

Side-by-side financial comparison of BRINKS CO (BCO) and Lakeside Holding Ltd (LSH). Click either name above to swap in a different company.

BRINKS CO is the larger business by last-quarter revenue ($1.4B vs $7.0M, roughly 196.6× Lakeside Holding Ltd). BRINKS CO runs the higher net margin — 4.9% vs -22.6%, a 27.5% gap on every dollar of revenue. On growth, Lakeside Holding Ltd posted the faster year-over-year revenue change (95.0% vs 9.1%).

The Brink's Company is an American cash handling company, headquartered in Richmond, Virginia. Its operations include cash-in-transit, ATM replenishment & maintenance, and cash management & payment services, such as vault outsourcing, money processing, intelligent safe services, and international transportation of valuables.

Lakeside Press was a Chicago publishing imprint under which the RR Donnelley Company produced fine books as well as mail order catalogs, telephone directories, encyclopedias, and advertising. The Press was best known for its high quality editions for the Chicago Caxton Club as well as the Lakeside Classics, a series of fine reprints.

BCO vs LSH — Head-to-Head

Bigger by revenue
BCO
BCO
196.6× larger
BCO
$1.4B
$7.0M
LSH
Growing faster (revenue YoY)
LSH
LSH
+86.0% gap
LSH
95.0%
9.1%
BCO
Higher net margin
BCO
BCO
27.5% more per $
BCO
4.9%
-22.6%
LSH

Income Statement — Q4 2025 vs Q4 2025

Metric
BCO
BCO
LSH
LSH
Revenue
$1.4B
$7.0M
Net Profit
$68.1M
$-1.6M
Gross Margin
27.7%
27.2%
Operating Margin
13.1%
-21.3%
Net Margin
4.9%
-22.6%
Revenue YoY
9.1%
95.0%
Net Profit YoY
76.9%
18.7%
EPS (diluted)
$1.62
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCO
BCO
LSH
LSH
Q4 25
$1.4B
$7.0M
Q3 25
$1.3B
$6.1M
Q2 25
$1.3B
$6.3M
Q1 25
$1.2B
$3.8M
Q4 24
$1.3B
$3.6M
Q3 24
$1.3B
$4.1M
Q2 24
$1.3B
Q1 24
$1.2B
Net Profit
BCO
BCO
LSH
LSH
Q4 25
$68.1M
$-1.6M
Q3 25
$36.3M
$-1.4M
Q2 25
$43.7M
$-893.1K
Q1 25
$51.6M
$-1.1M
Q4 24
$38.5M
$-1.9M
Q3 24
$28.9M
$-1.3M
Q2 24
$46.2M
Q1 24
$49.3M
Gross Margin
BCO
BCO
LSH
LSH
Q4 25
27.7%
27.2%
Q3 25
25.8%
18.2%
Q2 25
24.9%
26.7%
Q1 25
24.6%
18.8%
Q4 24
26.1%
-1.2%
Q3 24
25.0%
12.8%
Q2 24
25.2%
Q1 24
25.0%
Operating Margin
BCO
BCO
LSH
LSH
Q4 25
13.1%
-21.3%
Q3 25
11.4%
-20.8%
Q2 25
10.3%
-8.9%
Q1 25
9.6%
-28.2%
Q4 24
8.3%
-55.6%
Q3 24
8.9%
-32.5%
Q2 24
9.3%
Q1 24
9.8%
Net Margin
BCO
BCO
LSH
LSH
Q4 25
4.9%
-22.6%
Q3 25
2.7%
-22.2%
Q2 25
3.4%
-14.2%
Q1 25
4.1%
-28.2%
Q4 24
3.0%
-54.1%
Q3 24
2.3%
-32.7%
Q2 24
3.7%
Q1 24
4.0%
EPS (diluted)
BCO
BCO
LSH
LSH
Q4 25
$1.62
$-0.08
Q3 25
$0.86
$-0.09
Q2 25
$1.03
$-0.11
Q1 25
$1.18
$-0.14
Q4 24
$0.87
$-0.26
Q3 24
$0.65
$-0.18
Q2 24
$1.02
Q1 24
$1.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCO
BCO
LSH
LSH
Cash + ST InvestmentsLiquidity on hand
$1.7B
$1.6M
Total DebtLower is stronger
$4.0B
$2.4M
Stockholders' EquityBook value
$277.7M
$12.2M
Total Assets
$7.3B
$24.3M
Debt / EquityLower = less leverage
14.31×
0.20×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCO
BCO
LSH
LSH
Q4 25
$1.7B
$1.6M
Q3 25
$1.3B
$4.5M
Q2 25
$1.4B
$5.0M
Q1 25
$1.2B
$1.5M
Q4 24
$1.4B
$1.1M
Q3 24
$1.2B
$2.7M
Q2 24
$1.2B
Q1 24
$1.1B
Total Debt
BCO
BCO
LSH
LSH
Q4 25
$4.0B
$2.4M
Q3 25
$3.8B
$2.4M
Q2 25
$3.9B
$1.4M
Q1 25
$3.7B
$774.2K
Q4 24
$3.7B
$784.8K
Q3 24
$3.7B
$589.9K
Q2 24
$3.6B
Q1 24
$3.4B
Stockholders' Equity
BCO
BCO
LSH
LSH
Q4 25
$277.7M
$12.2M
Q3 25
$268.5M
$7.0M
Q2 25
$254.6M
$2.8M
Q1 25
$205.8M
$749.8K
Q4 24
$184.9M
$1.6M
Q3 24
$277.1M
$3.6M
Q2 24
$320.5M
Q1 24
$396.4M
Total Assets
BCO
BCO
LSH
LSH
Q4 25
$7.3B
$24.3M
Q3 25
$7.0B
$18.6M
Q2 25
$7.1B
$14.4M
Q1 25
$6.6B
$9.9M
Q4 24
$6.6B
$9.8M
Q3 24
$6.7B
$10.8M
Q2 24
$6.6B
Q1 24
$6.7B
Debt / Equity
BCO
BCO
LSH
LSH
Q4 25
14.31×
0.20×
Q3 25
14.05×
0.35×
Q2 25
15.48×
0.48×
Q1 25
18.19×
1.03×
Q4 24
20.26×
0.48×
Q3 24
13.39×
0.16×
Q2 24
11.26×
Q1 24
8.67×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCO
BCO
LSH
LSH
Operating Cash FlowLast quarter
$-453.5K
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCO
BCO
LSH
LSH
Q4 25
$-453.5K
Q3 25
$122.1M
$-4.0M
Q2 25
$-483.7K
Q1 25
$-60.2M
$-238.3K
Q4 24
$369.8M
$-530.2K
Q3 24
$58.4M
$-1.4M
Q2 24
$-66.1M
Q1 24
$63.9M
Free Cash Flow
BCO
BCO
LSH
LSH
Q4 25
Q3 25
$77.4M
Q2 25
$-497.4K
Q1 25
$-119.1M
Q4 24
$307.2M
$-560.5K
Q3 24
$7.4M
$-1.4M
Q2 24
$-122.8M
Q1 24
$11.7M
FCF Margin
BCO
BCO
LSH
LSH
Q4 25
Q3 25
5.8%
Q2 25
-7.9%
Q1 25
-9.6%
Q4 24
24.3%
-15.6%
Q3 24
0.6%
-34.5%
Q2 24
-9.8%
Q1 24
0.9%
Capex Intensity
BCO
BCO
LSH
LSH
Q4 25
3.5%
Q3 25
3.3%
Q2 25
4.0%
0.2%
Q1 25
4.7%
0.0%
Q4 24
5.0%
0.8%
Q3 24
4.1%
0.1%
Q2 24
4.5%
Q1 24
4.2%
Cash Conversion
BCO
BCO
LSH
LSH
Q4 25
Q3 25
3.36×
Q2 25
Q1 25
-1.17×
Q4 24
9.61×
Q3 24
2.02×
Q2 24
-1.43×
Q1 24
1.30×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCO
BCO

Segment breakdown not available.

LSH
LSH

Transferred Over Time$4.6M65%
Distribution Of Pharmaceutical Products$2.4M35%

Related Comparisons